Details of the Drug

General Information of Drug (ID: DM4JRE4)

Drug Name
CTL119
Indication
Disease Entry ICD 11 Status REF
Acute lymphocytic leukaemia 2B33.3 Phase 1 [1]
Cross-matching ID
TTD ID
D0LE5N

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)